Obesity-Related Hypogonadism in Women
Endocrine Reviews · 04.03.2024 · 45 (2) · 171-189
DOI: 10.1210/endrev/bnad027 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Endocrine Reviews, online erschienen am 10.08.2023. Verfasst von Pei Chia Eng und 12 weiteren Autor:innen. Beteiligte Einrichtung: Section of Endocrinology and Investigative Medicine, Imperial College London, London W12 0NN, UK. Hauptthemen laut MEDLINE: Hypogonadism, Polycystic Ovary Syndrome. Die Arbeit wurde bisher 78-mal zitiert (Crossref) und nennt 231 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MRC, NIHR, Imperial Clinical Research Facility.
Abstract (Originalsprache)
Obesity-related hypogonadotropic hypogonadism is a well-characterized condition in men (termed male obesity-related secondary hypogonadism; MOSH); however, an equivalent condition has not been as clearly described in women. The prevalence of polycystic ovary syndrome (PCOS) is known to increase with obesity, but PCOS is more typically characterized by increased gonadotropin-releasing hormone (GnRH) (and by proxy luteinizing hormone; LH) pulsatility, rather than by the reduced gonadotropin levels observed in MOSH. Notably, LH levels and LH pulse amplitude are reduced with obesity, both in women with and without PCOS, suggesting that an obesity-related secondary hypogonadism may also exist in women akin to MOSH in men. Herein, we examine the evidence for the existence of a putative non-PCOS “female obesity-related secondary hypogonadism” (FOSH). We précis possible underlying mechanisms for the occurrence of hypogonadism in this context and consider how such mechanisms differ from MOSH in men, and from PCOS in women without obesity. In this review, we consider relevant etiological factors that are altered in obesity and that could impact on GnRH pulsatility to ascertain whether they could contribute to obesity-related secondary hypogonadism including: anti-Müllerian hormone, androgen, insulin, fatty acid, adiponectin, and leptin. More precise phenotyping of hypogonadism in women with obesity could provide further validation for non-PCOS FOSH and preface the ability to define/investigate such a condition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Section of Endocrinology and Investigative Medicine, Imperial College London, London W12 0NN, UK.
- Department of Endocrinology, National University of Singapore, Singapore 117549.
- Department of Endocrinology, Imperial College Healthcare NHS Trust, London W12 0NN, UK.
ORCID-Profile: Pei Chia Eng, Tricia Tan, Ali Abbara
Förderung
- MRC
- NIHR
- Imperial Clinical Research Facility
- UK National Health Service
- UK Department of Health
Zitieren
APA
Eng, P. C., Phylactou, M., Qayum, A., Woods, C., Lee, H., Aziz, S., Moore, B., Miras, A. D., Comninos, A. N., Tan, T., Franks, S., Dhillo, W. S., & Abbara, A. (2024). Obesity-Related Hypogonadism in Women. Endocrine Reviews, 45(2), 171-189. https://doi.org/10.1210/endrev/bnad027
Vancouver
Eng PC, Phylactou M, Qayum A, Woods C, Lee H, Aziz S, et al. Obesity-Related Hypogonadism in Women. Endocrine Reviews. 2024;45(2):171-189. doi:10.1210/endrev/bnad027
BibTeX
@article{Eng2024,
author = {Eng, Pei Chia and Phylactou, Maria and Qayum, Ambreen and Woods, Casper and Lee, Hayoung and Aziz, Sara and Moore, Benedict and Miras, Alexander D and Comninos, Alexander N and Tan, Tricia and Franks, Steve and Dhillo, Waljit S and Abbara, Ali},
title = {Obesity-Related Hypogonadism in Women},
journal = {Endocrine Reviews},
year = {2024},
volume = {45},
number = {2},
pages = {171--189},
doi = {10.1210/endrev/bnad027}
}
EUVIMED